MondayJul 30, 2018 1:33 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Signs Cannabis Extraction Deal with Cannabis Strategic Ventures (OTC: NUGS)

Sunniva’s CP Logistics to produce ultra-purified extracts under Cannabis Strategic Ventures’ Pure Organix™ brand Investment banking firm Canaccord Genuity initiates coverage of Sunniva Canaccord Genuity gives Sunniva positive share price valuation above current market performance and a “speculative buy” rating Vertically integrated cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) has announced an agreement to produce top-quality cannabis extracts for Cannabis Strategic Ventures, Inc. (OTC: NUGS) (http://cnw.fm/B3aVh). Under the white label services agreement, Sunniva’s CP Logistics (“CPL”) subsidiary will produce ultra-purified cannabis extracts for the Pure Organix™ brand, owned by Cannabis Strategic’s subsidiary, Pure Applied Sciences, Inc. From its Sun-Oil Facility in Cathedral…

Continue Reading

FridayJul 27, 2018 12:46 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Establishes Business Unit for $55 Billion Medical Marijuana Market

Medical indications for marijuana multiply Medical marijuana (MMJ) market moves mainstream New cannabis business unit to focus on MMJ market Now that some 44 nations around the globe have passed laws allowing marijuana for medical use, the market is set for rapid expansion in the coming years. Industry analysts Grand View Research estimate that the global medical marijuana market will reach a value of $55.8 billion by 2025, as the range of therapies for cannabis multiplies (http://cnw.fm/8dEr3). Much of this expected demand will be driven by treatments for chronic pain, but applications are also likely to be developed for a number of other…

Continue Reading

ThursdayJul 26, 2018 12:41 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH May Play Larger Role in Treating Nervous System Disorders and Diseases

LXRP files for patent with the USPTO for DehydraTECH’s innovative treatment options for diseases and disorders including Alzheimer’s, Huntington’s and Parkinson’s Company hopes to leverage this future possible patent to commercialize its development or out-licensing of future new products that treat central nervous system diseases DehydraTECH platform, being lab tested for drug delivery, effectively transported nicotine across the blood brain barrier, a barrier that protects the brain and makes traditional treatment difficult Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH™ drug delivery platform has already received some eight patents granted and nearly 50 pending worldwide, and the company has…

Continue Reading

WednesdayJul 25, 2018 12:46 pm

PreveCeutical Medical’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Breakthrough Sol-gel Drug Delivery Platform Featured in Proactive Investors Interview

PreveCeutical was recently featured in an interview by Proactive Investors The company is currently developing its Sol-gel drug delivery platform for delivery of cannabinoids Sol-gel technology is paving the way for direct nose-to-brain drug delivery Innovative health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was recently featured by Proactive Investors in a “Corporate News Update” regarding the company’s potentially game-changing Sol-gel drug delivery platform (http://cnw.fm/Xm1tL).  The company earlier provided a written press release updating the Sol-gel program (http://cnw.fm/L2Lxb). Sol-gel, a nickname for soluble gel, is taken through nasal (systemic) administration and quickly gels once it comes in…

Continue Reading

TuesdayJul 24, 2018 1:58 pm

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Applicable to Multiple Industries

Active investigation phase in the EU, Canada, China, Japan and India Forming four new wholly owned subsidiaries Seeks to acquire an equitable tax treatment Cannabinoids are poorly absorbed by the body’s gastrointestinal tract, a trait that Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) lipophilic enhancement technology DehydraTECH™ is changing. Previously, consumers have turned to cannabis smoking to achieve higher effectiveness. However, human clinical studies have shown DehydraTECH™ to have a quick rate of absorption, allowing users to avoid the risks associated with smoking. DehydraTECH™ offers improved taste and smell, with effects felt within 15 to 20 minutes as opposed to…

Continue Reading

MondayJul 23, 2018 11:20 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Proceeding with Reorgani-zation into Four Subsidiaries

LXRP’s patented DehydraTECH technology will be employed by each wholly owned subsidiary, with applications applied to the industry segments At its 2018 Annual General and Special Meeting (AGM), all motions were passed, including election of board members and approval of its conversion plan Move to convert the company from a U.S.-based firm to Canada-based is placed on ‘indefinite hold’ due to inequitable tax treatment issue; LXRP to seek a resolution At Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) 2018 Annual General Meeting, all motions were passed. The company is proceeding on schedule with its reorganization into four new wholly owned…

Continue Reading

MondayJul 16, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO Outlines Next Steps for Promising New Technologies

Company is targeting $3.8 trillion preventative medicine industry Sol-gel delivery system administers CBD-based medicines directly to the brain via nasal passages Company R&D includes anti-diabetes and obesity gene therapy and powerful non-addictive painkiller Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) expects to make promising progress in the research and development of a number of exciting products in 2018, according to the company’s chairman, CEO and President Stephen Van Deventer in an audio interview (http://cnw.fm/7CrAF). He explained that, while pharmaceutical and nutraceutical companies are well-established, there is a relatively untapped $3.8 trillion a year industry in preventative…

Continue Reading

FridayJul 13, 2018 12:43 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Spinoff Canadian Assets to Unlock Underlying Value

New Canadian assets to be listed on the Toronto Stock Exchange and Nasdaq Sunniva’s U.S. assets to remain listed on the Canadian Securities Exchange (CSE) under the ticker symbol ‘SNN’ Two-year contract signed with industry leading Canopy Growth Corp. for 45 percent of production at Sunniva Canada Campus in British Columbia Sunniva anticipates launching its first line of Sunniva-branded products in the U.S. in Q3 2018 Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis company headquartered in Vancouver, Canada, and operating in the world’s two largest cannabis markets – Canada and California – is reaping positive attention with the…

Continue Reading

ThursdayJul 05, 2018 1:03 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Chronic Disease, Preventive Healthcare Market

Global preventive healthcare technologies and services market expected to reach $432 billion by 2024 Centers for Disease Control (CDC) states that seven out of 10 U.S. deaths are caused by chronic diseases such as diabetes, with global cost of treating diabetes reaching $776 billion within two decades World Health Organization recommended in December 2017 that cannabidiol (CBD) should not be scheduled as a controlled substance, citing its potential as a beneficial pharmaceutical PreveCeutical’s CBD-based Sol-gel delivery platform offers ease of application, better bioavailability and controlled cannabidiol release PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), headquartered in Vancouver, British…

Continue Reading

ThursdayJul 05, 2018 12:30 pm

Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) Seed to Sale Setup Sizzles in World’s Two Largest Cannabis Markets

Operating in world’s two largest cannabis markets – California and Canada Vertically integrated structure extracts value along the supply chain Pre-production sales strategy mitigates risk What can you give a company, like Vancouver, British Columbia-based Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), that seems to have everything? For starters, this vertically-integrated producer of medical and recreational cannabis has a presence in California and Canada, the world's two largest cannabis markets. Through several wholly-owned subsidiaries, it has operations in cannabis grow facilities, cannabis extraction facilities, medical cannabis clinics and the cannabis white label business. Moreover, a large part of its estimated total…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977